secwatch.observer — SEC 8-K summary
======================================

Issuer:     ImageneBio, Inc. (IMA)
CIK:        0001835579
Form:       8-K
Filed at:   2022-12-19T23:59:59+00:00
Accession:  0001193125-22-308371
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ikena Oncology appoints Owen Hughes as Board Chair; Ron Renaud resigns
----------------------------------------------------------------------

- Owen Hughes appointed to Board and as Chairman, effective Dec 15, 2022; fills vacancy from board expansion then reduction.
- Ron Renaud resigned as Chairman and Board member to focus on role as Managing Director at Bain Capital Life Sciences; no dispute.
- Hughes also named Chair of Audit Committee and member of Compensation Committee; designated audit committee financial expert.
- Hughes is CEO of Sail Bio and Co-Founder of Cullinan Oncology; brings public company board experience.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1835579/000119312522308371/0001193125-22-308371-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1835579/000119312522308371/d409932d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-308371

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer